Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA603610
Max Phase: Preclinical
Molecular Formula: C20H23N3O4
Molecular Weight: 369.42
Molecule Type: Small molecule
Associated Items:
ID: ALA603610
Max Phase: Preclinical
Molecular Formula: C20H23N3O4
Molecular Weight: 369.42
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1ccc(C(=O)N[C@H](C(=O)N/N=C/c2ccc(C)cc2)C(C)O)cc1
Standard InChI: InChI=1S/C20H23N3O4/c1-13-4-6-15(7-5-13)12-21-23-20(26)18(14(2)24)22-19(25)16-8-10-17(27-3)11-9-16/h4-12,14,18,24H,1-3H3,(H,22,25)(H,23,26)/b21-12+/t14?,18-/m0/s1
Standard InChI Key: KEZGCFSHMQNADB-BOKGVYLRSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 369.42 | Molecular Weight (Monoisotopic): 369.1689 | AlogP: 1.63 | #Rotatable Bonds: 7 |
Polar Surface Area: 100.02 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 11.53 | CX Basic pKa: 1.77 | CX LogP: 2.15 | CX LogD: 2.15 |
Aromatic Rings: 2 | Heavy Atoms: 27 | QED Weighted: 0.51 | Np Likeness Score: -0.97 |
1. Jin Y, Tan Z, He M, Tian B, Tang S, Hewlett I, Yang M.. (2010) SAR and molecular mechanism study of novel acylhydrazone compounds targeting HIV-1 CA., 18 (6): [PMID:20188575] [10.1016/j.bmc.2010.02.003] |
Source(1):